Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing
Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35